Elusive EU Clinical Trial Rules Slip Again – Now To Late 2018
This article was originally published in The Pink Sheet Daily
Executive Summary
EMA board says it's "critical" that the complex new program provides the "required functionalities to all stakeholders in the most efficient and stable way from the start of its operations."